These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1012 related items for PubMed ID: 24111570

  • 1. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W, Fujita T.
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [Abstract] [Full Text] [Related]

  • 2. Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways.
    Nishimoto M, Fujita T.
    Am J Physiol Renal Physiol; 2015 Mar 01; 308(5):F377-87. PubMed ID: 25520008
    [Abstract] [Full Text] [Related]

  • 3. Role of Rac1 GTPase in salt-sensitive hypertension.
    Nagase M.
    Curr Opin Nephrol Hypertens; 2013 Mar 01; 22(2):148-55. PubMed ID: 23377658
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M, Fujita T.
    Hypertens Res; 2009 Aug 01; 32(8):649-57. PubMed ID: 19521418
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T.
    Hypertension; 2007 Nov 01; 50(5):877-83. PubMed ID: 17875821
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.
    Kawarazaki W, Nagase M, Yoshida S, Takeuchi M, Ishizawa K, Ayuzawa N, Ueda K, Fujita T.
    J Am Soc Nephrol; 2012 Jun 01; 23(6):997-1007. PubMed ID: 22440899
    [Abstract] [Full Text] [Related]

  • 10. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.
    Nagase M.
    Clin Exp Nephrol; 2010 Aug 01; 14(4):303-14. PubMed ID: 20533072
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
    Kawarazaki H, Ando K, Fujita M, Matsui H, Nagae A, Muraoka K, Kawarasaki C, Fujita T.
    Am J Physiol Renal Physiol; 2011 Jun 01; 300(6):F1402-9. PubMed ID: 21478481
    [Abstract] [Full Text] [Related]

  • 13. The Role of Aldosterone in Obesity-Related Hypertension.
    Kawarazaki W, Fujita T.
    Am J Hypertens; 2016 Apr 01; 29(4):415-23. PubMed ID: 26927805
    [Abstract] [Full Text] [Related]

  • 14. Corticosterone-activated mineralocorticoid receptor contributes to salt-induced sympathoexcitation in pressure overload mice.
    Ito K, Hirooka Y, Sunagawa K.
    Clin Exp Hypertens; 2014 Apr 01; 36(8):550-6. PubMed ID: 24490674
    [Abstract] [Full Text] [Related]

  • 15. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Kawarazaki H, Ando K, Nagae A, Fujita M, Matsui H, Fujita T.
    Nephrol Dial Transplant; 2010 Sep 01; 25(9):2879-89. PubMed ID: 20466668
    [Abstract] [Full Text] [Related]

  • 16. Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway.
    Mao J, Zhang X, Wang C, Peng S.
    Clin Exp Hypertens; 2024 Dec 31; 46(1):2402258. PubMed ID: 39277848
    [Abstract] [Full Text] [Related]

  • 17. Role of mineralocorticoid action in the brain in salt-sensitive hypertension.
    Oki K, Gomez-Sanchez EP, Gomez-Sanchez CE.
    Clin Exp Pharmacol Physiol; 2012 Jan 31; 39(1):90-5. PubMed ID: 21585422
    [Abstract] [Full Text] [Related]

  • 18. The kidneys and aldosterone/mineralocorticoid receptor system in salt-sensitive hypertension.
    Shibata S, Fujita T.
    Curr Hypertens Rep; 2011 Apr 31; 13(2):109-15. PubMed ID: 21207253
    [Abstract] [Full Text] [Related]

  • 19. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
    Bayorh MA, Ganafa AA, Emmett N, Socci RR, Eatman D, Fridie IL.
    Clin Exp Hypertens; 2005 May 31; 27(4):355-67. PubMed ID: 15921072
    [Abstract] [Full Text] [Related]

  • 20. Mineralocorticoid receptor activation as an etiological factor in kidney diseases.
    Ueda K, Nagase M.
    Clin Exp Nephrol; 2014 Feb 31; 18(1):16-23. PubMed ID: 23832326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.